1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Treatment Method
1.2.1 Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Treatment Method: 2018 VS 2022 VS 2030
1.2.2 Androgen Receptor-Directed Therapy
1.2.3 Taxane-Based Chemotherapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics and Therapy Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics and Therapy Market Perspective (2018-2030)
2.2 Prostate Cancer Diagnostics and Therapy Growth Trends by Region
2.2.1 Prostate Cancer Diagnostics and Therapy Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Prostate Cancer Diagnostics and Therapy Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Region (2023-2030)
2.3 Prostate Cancer Diagnostics and Therapy Market Dynamics
2.3.1 Prostate Cancer Diagnostics and Therapy Industry Trends
2.3.2 Prostate Cancer Diagnostics and Therapy Market Drivers
2.3.3 Prostate Cancer Diagnostics and Therapy Market Challenges
2.3.4 Prostate Cancer Diagnostics and Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Diagnostics and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnostics and Therapy Revenue
3.4 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics and Therapy Revenue in 2022
3.5 Prostate Cancer Diagnostics and Therapy Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnostics and Therapy Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnostics and Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnostics and Therapy Breakdown Data by Treatment Method
4.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Treatment Method (2018-2023)
4.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Treatment Method (2023-2030)
5 Prostate Cancer Diagnostics and Therapy Breakdown Data by Application
5.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Prostate Cancer Diagnostics and Therapy Market Size (2018-2030)
6.2 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2018-2023)
6.3 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnostics and Therapy Market Size (2018-2030)
7.2 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2018-2023)
7.3 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size (2018-2030)
8.2 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Country (2018-2023)
8.3 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnostics and Therapy Market Size (2018-2030)
9.2 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2018-2023)
9.3 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size (2018-2030)
10.2 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2018-2023)
10.3 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Ipsen SA
11.1.1 Ipsen SA Company Detail
11.1.2 Ipsen SA Business Overview
11.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Introduction
11.1.4 Ipsen SA Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.1.5 Ipsen SA Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.2.4 Pfizer Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.2.5 Pfizer Inc. Recent Development
11.3 Johnson & Johnson Services Inc.
11.3.1 Johnson & Johnson Services Inc. Company Detail
11.3.2 Johnson & Johnson Services Inc. Business Overview
11.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.3.4 Johnson & Johnson Services Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.3.5 Johnson & Johnson Services Inc. Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Introduction
11.4.4 Bayer AG Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.4.5 Bayer AG Recent Development
11.5 Abbvie Inc.
11.5.1 Abbvie Inc. Company Detail
11.5.2 Abbvie Inc. Business Overview
11.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.5.4 Abbvie Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.5.5 Abbvie Inc. Recent Development
11.6 Merck & Co. Inc.
11.6.1 Merck & Co. Inc. Company Detail
11.6.2 Merck & Co. Inc. Business Overview
11.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.6.4 Merck & Co. Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.6.5 Merck & Co. Inc. Recent Development
11.7 AstraZeneca PLC
11.7.1 AstraZeneca PLC Company Detail
11.7.2 AstraZeneca PLC Business Overview
11.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Introduction
11.7.4 AstraZeneca PLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.7.5 AstraZeneca PLC Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Introduction
11.8.4 Thermo Fisher Scientific Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Dendreon Pharmaceuticals LLC
11.9.1 Dendreon Pharmaceuticals LLC Company Detail
11.9.2 Dendreon Pharmaceuticals LLC Business Overview
11.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Introduction
11.9.4 Dendreon Pharmaceuticals LLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.9.5 Dendreon Pharmaceuticals LLC Recent Development
11.10 F. Hoffmann-La Roche Ltd
11.10.1 F. Hoffmann-La Roche Ltd Company Detail
11.10.2 F. Hoffmann-La Roche Ltd Business Overview
11.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Introduction
11.10.4 F. Hoffmann-La Roche Ltd Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.10.5 F. Hoffmann-La Roche Ltd Recent Development
11.11 Hologic Inc.
11.11.1 Hologic Inc. Company Detail
11.11.2 Hologic Inc. Business Overview
11.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.11.4 Hologic Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.11.5 Hologic Inc. Recent Development
11.12 Astellas Pharma Inc.
11.12.1 Astellas Pharma Inc. Company Detail
11.12.2 Astellas Pharma Inc. Business Overview
11.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Introduction
11.12.4 Astellas Pharma Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.12.5 Astellas Pharma Inc. Recent Development
11.13 Koninklijke Philips NV
11.13.1 Koninklijke Philips NV Company Detail
11.13.2 Koninklijke Philips NV Business Overview
11.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Introduction
11.13.4 Koninklijke Philips NV Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.13.5 Koninklijke Philips NV Recent Development
11.14 Sanofi-Aventis
11.14.1 Sanofi-Aventis Company Detail
11.14.2 Sanofi-Aventis Business Overview
11.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Introduction
11.14.4 Sanofi-Aventis Revenue in Prostate Cancer Diagnostics and Therapy Business (2018-2023)
11.14.5 Sanofi-Aventis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
